Candel Therapeutics, Inc.
CADL
$5.73
$0.0210.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 100.69M | 92.17M | 102.65M | 16.56M | 21.45M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.92M | 983.00K | 1.15M | 1.53M | 1.28M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 103.61M | 93.15M | 103.80M | 18.09M | 22.74M |
|
|
|||||
| Total Current Assets | 103.61M | 93.15M | 103.80M | 18.09M | 22.74M |
| Net Property, Plant & Equipment | 2.05M | 2.43M | 2.73M | 3.09M | 3.40M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 311.00K | 324.00K | 329.00K | 341.00K | 347.00K |
| Total Assets | 105.97M | 95.91M | 106.87M | 21.52M | 26.49M |
|
|
|||||
| Total Accounts Payable | 1.95M | 760.00K | 237.00K | 296.00K | 433.00K |
| Total Accrued Expenses | 4.05M | 2.41M | 4.72M | 4.57M | 3.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.30M | 9.75M | 10.46M | 10.40M | 10.35M |
| Total Finance Division Other Current Liabilities | 1.41M | 7.15M | 22.11M | -- | -- |
| Total Other Current Liabilities | 1.41M | 7.15M | 22.11M | -- | -- |
| Total Current Liabilities | 14.72M | 20.07M | 37.53M | 15.27M | 14.00M |
|
|
|||||
| Total Current Liabilities | 14.72M | 20.07M | 37.53M | 15.27M | 14.00M |
| Long-Term Debt | 939.00K | 904.00K | 2.60M | 5.07M | 7.52M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 104.00K | 257.00K | 407.00K | 555.00K | 698.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 15.89M | 14.25M |
| Total Liabilities | 15.76M | 21.23M | 40.54M | 36.77M | 36.46M |
|
|
|||||
| Common Stock & APIC | 280.28M | 259.95M | 258.98M | 163.32M | 157.96M |
| Retained Earnings | -189.62M | -184.83M | -192.21M | -178.13M | -167.49M |
| Treasury Stock & Other | -448.00K | -448.00K | -448.00K | -448.00K | -448.00K |
| Total Common Equity | 90.21M | 74.68M | 66.33M | -15.26M | -9.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 90.21M | 74.68M | 66.33M | -15.26M | -9.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 90.21M | 74.68M | 66.33M | -15.26M | -9.97M |
|
|
|||||